Here are three notes:
1. The $49.25 per share offer from TPG Capital is a 17.3 percent increase to its $42 per share offer in October.
2. Exatech’s board agreed to the amended terms and expects to close the all-cash deal during the first quarter of 2018.
3. When the deal was announced Oct. 23, Exatech’s stock has hovered at $42. However, on Monday, Dec. 4, the company’s stock was trading at $49.25.
More articles on devices and implants:
Global spinal fusion devices market to reach nearly $11B by 2025: 6 observations
Mazor Robotics CEO under investigation for insider trading: 3 things to know
Precision Medical opens 3rd Indiana location — 6 notes
